A bankruptcy judge has approved the sale of the insolvent genetics firm 23andMe to a nonprofit run by one of the company's co-founders. The deal effectively avoids the controversial transfer of DNA data to a third party.

The prospect of 23andMe's trove of genetic information on millions of people passing to the highest bidder had sparked outcry when it was announced in May that New York-based Regeneron Pharmaceuticals had won an auction to acquire the firm for $256 million.

Details may be found at: https://www.npr.org/2025/06/30/nx-s1-5451398/23andme-sale-approved-dna-data